A Phase II Study of Second-Line Neoadjuvant Chemotherapy With Capecitabine and Radiation Therapy for Anthracycline-Resistant Locally Advanced Breast Cancer-Reference-Cited by-同舟云学术

A Phase II Study of Second-Line Neoadjuvant Chemotherapy With Capecitabine and Radiation Therapy for Anthracycline-Resistant Locally Advanced Breast Cancer

Published:2007-02 Issue:1 Volume:30 Page:78-81
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:American Journal of Clinical Oncology

Author:

Gaui Maria de F??tima Dias,Amorim Gilberto,Arcuri Roberto Alfonso,Pereira Guilherme,Moreira Denise,Djahjah C??lia,Biasoli Irene,Spector Nelson

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference13 articles.

1. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy

2. Treatment of Breast Cancer in Countries with Limited Resources

3. Locoregional treatment outcomes for inoperable anthracycline-resistant breast cancer

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommandations francophones pour la pratique clinique concernant la prise en charge des cancers du sein de Saint-Paul-de-Vence 2022-2023;Bulletin du Cancer;2023-11

2. ¿Está indicada la radioterapia o la radioquimioterapia primaria?;Revista de Senología y Patología Mamaria;2023-10

3. Feasibility and Tolerability of Adjuvant Capecitabine–Based Chemoradiation in Patients With Breast Cancer and Residual Disease After Neoadjuvant Chemotherapy: A Prospective Clinical Trial;International Journal of Radiation Oncology*Biology*Physics;2023-07

4. Comprehensive Profiling of Cancer-Associated Cells in the Blood of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy to Predict Pathological Complete Response;Bioengineering;2023-04-18

5. The Role of Radiotherapy for Patients with Unresectable Locally Advanced Breast Cancer following Neoadjuvant Systemic Therapy;Journal of Oncology;2023-02-17